BeStock  

Zimmer Biomet Holdings ZBH

US equityMarket cap rank #937Medical Devices
$101.10 −$0.37 (-0.36%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $100.82 -0.28%
Open$102.72
Prev close$101.47
Day range$100.82 – $103.87
Volume2.96M
Market cap$19.13B
P/E (TTM)25.5
Dividend yield0.95%

Earnings

Average move on report day±5.9%last 16 reports
Closed higher7 of 1644% of the time
Best reaction+13.5%
Worst reaction-15.1%

Stock move on the day after each report

-3.5%2023/Q4-0.9%2024/Q1-3.4%2024/Q2+5.7%2024/Q3-5.1%2024/Q4-11.6%2025/Q1+8.0%2025/Q2-15.1%2025/Q3+1.9%2025/Q4-10.6%2026/Q1+2.5%2026/Q2+13.5%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q34 Nov 2026Pre Market±6.4%+13.49%Bigger than priced
2026/Q25 Aug 2026Pre Market±6.3%+2.45%Within range
2026/Q128 Apr 2026Pre Market±5.5%-10.57%Bigger than priced
2025/Q410 Feb 2026Pre Market±6.8%+1.86%Within range
2025/Q35 Nov 2025Pre Market±6.3%-15.15%Bigger than priced
2025/Q27 Aug 2025Pre Market±10.8%+7.99%Within range
2025/Q15 May 2025Pre Market±7.3%-11.62%Bigger than priced
2024/Q46 Feb 2025Pre Market±5.8%-5.14%Within range
2024/Q330 Oct 2024Pre Market±8.1%+5.71%Within range
2024/Q27 Aug 2024Pre Market±7.0%-3.43%Within range
2024/Q12 May 2024Pre Market±7.1%-0.92%Within range
2023/Q48 Feb 2024Pre Market±5.8%-3.54%Within range
2023/Q37 Nov 2023Pre Market±6.9%-3.08%Within range
2023/Q21 Aug 2023Pre Market±5.7%-4.26%Within range
2023/Q12 May 2023Pre Market±5.5%+3.01%Within range
2022/Q43 Feb 2023Pre Market±6.3%+1.60%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Knees$767.50M 37.2%
  • Sports Medicine, Upper Extremities, Foot and Ankle; Trauma, Craniomaxillofacial and Thoracic (S.E.T)$578.30M 28.0%
  • Hips$536.50M 26.0%
  • Technology & Data, Bone Cement and Surgical$180.60M 8.8%

Latest reported quarter: Q3, ended Sep 2026

Revenue$2.06B+3.1% YoY
Operating profit$341.50M+0.9% YoY
Net profit$192.90M-16.6% YoY
Diluted EPS$1.00-13.8% YoY
Free cash flow$459.20M+29.8% YoY
Operating cash flow$560.00M

Revenue, last 8 quarters

$2.0BDec '24$1.9BMar '25$2.1BJun '25$2.0BSep '25$2.2BDec '25$2.1BMar '26$2.2BJun '26$2.1BSep '26

Net profit, last 8 quarters

$240.1MDec '24$182.6MMar '25$153.4MJun '25$231.2MSep '25$137.9MDec '25$238.3MMar '26$199.6MJun '26$192.9MSep '26

Profitability & balance sheet

Gross margin69.7%
Operating margin16.3%
Net margin9.0%
Return on equity6.0%
Return on assets3.3%
Return on invested capital5.0%
Current ratio1.46
Liabilities / assets45.9%
Cash & investments$399.90M
Total debt$7.50B
Net cash (debt)-$7.10B
Free cash flow / sales17.6%

Discussion

No comments yet — be the first to weigh in on ZBH.

Sign in to join the discussion.

Scroll to Top